乳腺细针穿刺细胞学评估肿瘤浸润淋巴细胞可预测组织学TILs
该回顾性研究纳入214例符合标准的乳腺细针穿刺细胞学样本,建立细胞学TILs评分(cTILs),并与组织学TILs比较。训练集中cTILs>8的AUC为0.943,验证集AUC为0.79,排除<0.5cm肿瘤后AUC升至0.93。结论认为cTILs对≥0.5cm肿瘤与组织学TILs一致性可接受,细胞学评估可能替代组织学评估。
要点
- cTILs评分通过淋巴细胞数减中性粒细胞数计算。
- 训练集cTILs>8阈值下敏感度87.5%、特异度90.5%。
- 验证集排除<0.5cm肿瘤后AUC为0.93。
核心结论
- cTILs评分系统对≥0.5cm的乳腺肿瘤与组织学TILs具有可接受的重现性和一致性。
- 细胞学评估有潜力替代组织学评估TILs。
研究设计与样本
- 回顾性研究,从1101例乳腺细针穿刺细胞学样本中纳入214例符合标准者。
- 组织学TILs以<60%和≥60%分为低和高两组。
- 构建训练集和验证集各50例乳腺癌样本。
主要发现
- 训练集中cTILs评分>8阈值的敏感度为87.5%、特异度为90.5%。
- 验证集中AUC为0.79(95%CI 0.6-0.93),敏感度57%、特异度89.5%。
- 排除<0.5cm小肿瘤后,验证集AUC提高至0.93(95%CI 0.83-1.0),敏感度80%、特异度88.5%。
关键数值与推荐
- 组织学TILs低组为<60%,高组为≥60%。
- cTILs评分=肿瘤细胞周围淋巴细胞数−中性粒细胞数。
- cTILs评分cutoff值>8。
临床怎么用
- 对≥0.5cm的乳腺肿瘤,可用FNAB细胞学cTILs评分辅助评估TILs状态。
- cTILs评分>8可提示高TILs,但需注意验证集敏感度较低。
局限性
- 回顾性研究,样本来自单中心。
- 验证集样本量较小(50例)。
- 小肿瘤<0.5cm一致性较差,需排除后AUC才提高。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Tumor-infiltrating lymphocytes (TILs) are associated with various clinicopathological features. Using cytologic specimens for assessing TILs remains to be established. This retrospective study aimed to establish a practical method to assess TILs in cytologic samples. METHODS: The authors found 1101 breast fine-needle aspiration biopsy (FNAB) cytology samples in their hospital, and 214 of them met the inclusion criteria. The TILs score was evaluated using histologic slides, and breast cancers were divided into 2 groups: low- (<60%) and high-TILs (≥60%). Training and validation tests composed of 50 breast cancer samples each were constructed. A cytologic TILs (cTILs) score was introduced to evaluate lymphocytes in FNAB cytology and it was compared with histologically evaluated TILs. The cTILs score was calculated by subtracting the number of neutrophils from the number of lymphocytes surrounding the tumor cells. RESULTS: In the training test, a 2-tier system with low- and high-TILs groups showed a large area under the curve (AUC) (0.943; 95% confidence interval [CI], 0.84-0.99). A cTILs score cutoff value of >8 had 87.5% sensitivity and 90.5% specificity. In the validation test, the AUC was 0.79 (95% CI, 0.6-0.93) whereas sensitivity and specificity were 57% and 89.5%, respectively. When small tumors <0.5 cm were excluded, the AUC improved to 0.93 (95% CI, 0.83-1.0), and sensitivity and specificity were 80% and 88.5%, respectively. CONCLUSIONS: The cTILs scoring system had acceptable reproducibility and concordance with TILs on histologic samples for tumors ≥0.5 cm. Cytologic evaluation can potentially substitute for histologic evaluation of TILs.
引用
- Odate T, Le MK, Kawai M, et al. Tumor-infiltrating lymphocytes in breast FNA biopsy cytology: A predictor of tumor-infiltrating lymphocytes in histologic evaluation. Cancer Cytopathol. 2022. PMID: 35129867. doi:10.1002/cncy.22551
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。